Pharmacokinetic interactions between clopidogrel and rosuvastatin: Effects on vascular protection in subjects with coronary heart disease

International Journal of Cardiology

Volumn 158, Issue 1, 2012, Pages 125-129

  Pinheiro, Luiz F ^a   França, Carolina N ^a   Izar, Maria C ^a,b   Barbosa, Simone P ^a   Bianco, Henrique T ^a   Kasmas, Soraia H ^a   Mendes, Gustavo D ^c   Povoa, Rui M ^a   Fonseca, Francisco A H ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Galeno Laboratory   (Brazil)

Author keywords

Clopidogrel; Endothelium; Lipids; Pharmacokinetics; Platelets; Rosuvastatin

Indexed keywords

CLOPIDOGREL; ROSUVASTATIN;

ADULT; AGED; AREA UNDER THE CURVE; CLINICAL EVALUATION; CORONARY ARTERY DISEASE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG POTENTIATION; HEART PROTECTION; HUMAN; LETTER; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MAXIMUM PLASMA CONCENTRATION; PRIORITY JOURNAL; THROMBOCYTE FUNCTION;

EID: 84862020205     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.04.051     Document Type: Article

References (36)

1. F.A. Spencer, G.C. Fonarow, P.D. Frederick, R.S. Wright, N. Every, and R.J. Goldberg National Registry of Myocardial Infarction. Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction Arch Intern Med 164 2004 2162 2168
2. G.C. Fonarow, R.S. Wright, and F.A. Spencer National Registry of Myocardial Infarction 4 Investigators. Effect of statin use within the first 24 hours of admission for acute myocardial infarction on early morbidity and mortality Am J Cardiol 96 2005 611 616
3. M. Nagashima, R. Koyanagi, H. Kasanuki, N. Hagiwara, J. Yamaguchi, and N. Atsuchi Heart Institute of Japan, Department of Cardiology (HIJC) Investigators. Effect of early statin treatment at standard doses on long-term clinical outcomes in patients with acute myocardial infarction (the Heart Institute of Japan, Department of Cardiology Statin Evaluation Program) Am J Cardiol 99 2007 1523 1528
4. R.S. Wright, K. Bybee, W.L. Miller, D.A. Laudon, J.G. Murphy, and A.S. Jaffe Reduced risks of death and CHF are associated with statin therapy administered acutely within the first 24 h of AMI Int J Cardiol 108 2006 314 319
5. G. Di Sciascio, G. Patti, V. Pasceri, A. Gaspardone, G. Colonna, and A. Montinaro Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial J Am Coll Cardiol 54 2009 558 565
6. G. Patti, C.P. Cannon, and S.A. Murphy Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies Circulation 123 2011 1622 1632
7. P. Di Napoli, A.A. Taccardi, and A. Grilli Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts Cardiovasc Res 66 2005 462 471
8. Q. Zhou, and J.K. Liao Pleiotropic effects of statins. Basic research and clinical perspectives Circ J 74 2010 818 826
9. M. Kazui, Y. Nishiya, and T. Ishizuka Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite Drug Metab Dispos 38 2010 92 99
10. U.S. Tantry, D.J. Kereiakes, and P.A. Gurbel Clopidogrel and proton pump inhibitors: influence of pharmacological interactions on clinical outcomes and mechanistic explanations JACC Cardiovasc Interv 4 2011 365 380
11. Y. Shitara, and Y. Sugiyama Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions Pharmacol Ther 112 2006 71 105
12. P. Libby, P.M. Ridker, and G.K. Hansson Progress and challenges in translating the biology of atherosclerosis Nature 473 2011 317 325
13. C.J. Boos, B. Balakrishnan, A.D. Blann, and G.Y. Lip The relationship of circulating endothelial cells to plasma indices of endothelial damage/dysfunction and apoptosis in acute coronary syndromes: implications for prognosis J Thromb Haemost 6 2008 1841 1850
14. G.P. Fadini, S. de Kreutzenberg, and C. Agostini Low CD34 + cell count and metabolic syndrome synergistically increase the risk of adverse outcomes Atherosclerosis 207 2009 213 219
15. E.F. da Silva, F.A. Fonseca, and C.N. França Imbalance between endothelial progenitor cells and microparticles in HIV-infected patients naive for antiretroviral therapy AIDS 25 2011 1595 1601
16. A.J.S. Coats, and L.G. Shewan Statement on authorship and publishing ethics in the International Journal of Cardiology Int J Cardiol 153 2011 257 258 10.1016/j.ijcard.2011.10.119
17. M. Endres, and U. Laufs Discontinuation of statin treatment in stroke patients Stroke 37 2006 2640 2643
18. C. Heeschen, C.W. Hamm, and U. Laufs Withdrawal of statins increases event rates in patients with acute coronary syndromes Circulation 105 2002 1446 1452
19. S. Skrlin, and V. Hou A review of perioperative statin therapy for noncardiac surgery Semin Cardiothorac Vasc Anesth 14 2010 283 290
20. L. Puccetti, A.L. Pasqui, and M. Pastorelli Platelet hyperactivity after statin treatment discontinuation Thromb Haemost 90 2003 476 482
21. S.A. Hunt, W.T. Abraham, and M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
22. N.J. Breet, J.W. van Werkum, and H.J. Bouman Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation JAMA 303 2010 754 762
23. D. Sibbing, S. Braun, and T. Morath Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis J Am Coll Cardiol 53 2009 849 856
24. P. Eshtehardi, S. Windecker, and S. Cook Dual low response to acetylsalicylic acid and clopidogrel is associated with myonecrosis and stent thrombosis after coronary stent implantation Am Heart J 159 2010 891 898
25. R. Nirogi, K. Mudigonda, and V. Kandikere Chromatography-mass spectrometry methods for the quantitation of statins in biological samples J Pharm Biomed Anal 44 2007 379 387
26. C.N. França, L.F. Pinheiro, and M.C. Izar Endothelial progenitor cell mobilization and platelet microparticle release are influenced by clopidogrel plasma levels in stable coronary heart disease Circ J 2011 Dec 28 [Epub ahead of print]
27. S.A. Brandão, M.C. Izar, and S.M. Fischer Early increase in autoantibodies against human oxidized low-density lipoprotein in hypertensive patients after blood pressure control Am J Hypertens 23 2010 208 214
28. K.M. Bailey, S.P. Romaine, and B.M. Jackson SPACE ROCKET Trial Group. Hepatic metabolism and transporter gene variants enhance response to rosuvastatin in patients with acute myocardial infarction: the GEOSTAT-1 Study Circ Cardiovasc Genet 3 2010 276 285
29. M. Endres, and U. Laufs Effects of statins on endothelium and signaling mechanisms Stroke 35 2004 2708 2711
30. S. Riondino, N. Petrini, and L. Donato Effects of rosuvastatin on platelet inhibition by clopidogrel in cardiovascular patients J Thromb Thrombolysis 28 2009 151 155
31. E.M. Vasina, S. Cauwenberghs, M.A. Feijge, J.W. Heemskerk, C. Weber, and R.R. Koenen Microparticles from apoptotic platelets promote resident macrophage differentiation Cell Death Dis 2 2011 e210
32. P.E. Rautou, A.C. Vion, and N. Amabile Microparticles, vascular function, and atherothrombosis Circ Res 109 2011 593 606
33. X.L. Tang, S.K. Sanganalmath, and H. Sato Atorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and remodeling after myocardial infarction PLoS One 6 2011 e25320
34. Y. Ye, J.R. Perez-Polo, and Y. Birnbaum Protecting against ischemia-reperfusion injury: antiplatelet drugs, statins, and their potential interactions Ann N Y Acad Sci 1207 2010 76 82
35. A. Zahno, K. Brecht, M. Bodmer, D. Bur, D.A. Tsakiris, and S. Krähenbühl Effects of drug interactions on biotransformation and antiplatelet effect of clopidogrel in vitro Br J Pharmacol 161 2010 393 404
36. N.A. Farid, D.S. Small, and C.D. Payne Effect of atorvastatin on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in healthy subjects Pharmacotherapy 28 2008 1483 11494